Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine

被引:85
作者
Mohammadi, Marzieh [1 ]
Ramezani, Mohammad [1 ,2 ]
Abnous, Khalil [2 ]
Alibolandi, Mona [2 ]
机构
[1] Mashhad Univ Med Sci, Nanotechnol Res Ctr, Mashhad, Iran
[2] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Mashhad, Iran
关键词
Polymersome; Theranostics; Cancer; Diagnostics; Copolymer; DOUBLE-EMULSION DROPLETS; DRUG-DELIVERY; QUANTUM DOTS; IN-VITRO; FUNCTIONALIZED POLYMERSOMES; BIODEGRADABLE POLYMERSOMES; MICROFLUIDIC FABRICATION; GOLD NANOPARTICLES; TARGETED DELIVERY; VESICLES;
D O I
10.1016/j.ijpharm.2017.01.037
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polymersomes are polymeric vesicles that have numerous advantages for theranostics, the integrated approach of therapeutics and diagnostics. Polymersomes possess core-shell structures which encapsulate hydrophilic molecules in the aqueous compartment and hydrophobic molecules in the bilayer of the vesicles. Polymersomes are made of different amphiphilic block copolymers. Thus, in the process of designing polymersomes, a variety of amphiphilic block copolymers with different molecular weights are used to develop intelligent or sustained released formulations and to modify the stability of the system and bilayer thickness or to functionalize the particle with targeting moieties to improve the delivery efficiency. In addition, biocompatible and/or biodegradable polymersomes are diverse in size and charge which show low toxicity in vivo. Polymersomes are increasingly being used as platforms for simultaneous drug delivery and imaging and are therefore becoming popular theranostic nanoparticles. This review focuses on the methods of nanoparticle formation when polymersomes for theranostic nanomedicine are engineered. We highlight recent examples of polymersome theranostic systems from literature and their potential for use in the clinic, particularly biodegradable or biocompatible-based NPs. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:287 / 303
页数:17
相关论文
共 102 条
[1]   Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo [J].
Alibolandi, Mona ;
Abnous, Khalil ;
Hadizadeh, Farzin ;
Taghdisi, Seyed Mohammad ;
Alabdollah, Fatemeh ;
Mohammadi, Marzieh ;
Nassirli, Hooriyeh ;
Ramezani, Mohammad .
JOURNAL OF CONTROLLED RELEASE, 2016, 241 :45-56
[2]   Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation [J].
Alibolandi, Mona ;
Abnous, Khalil ;
Sadeghi, Fatemeh ;
Hosseinkhani, Hossein ;
Ramezani, Mohammad ;
Hadizadeh, Farzin .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 500 (1-2) :162-178
[3]   The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model [J].
Alibolandi, Mona ;
Sadeghi, Fatemeh ;
Abnous, Khalil ;
Atyabi, Fatemeh ;
Ramezani, Mohammad ;
Hadizadeh, Farzin .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 94 :521-531
[4]   In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer [J].
Alibolandi, Mona ;
Ramezani, Mohammad ;
Abnous, Khalil ;
Sadeghi, Fatemeh ;
Atyabi, Fatemeh ;
Asouri, Mohsen ;
Ahmadi, Ali Asghar ;
Hadizadeh, Farzin .
JOURNAL OF CONTROLLED RELEASE, 2015, 209 :88-100
[5]   Comparative evaluation of polymersome versus micelle structures as vehicles for the controlled release of drugs [J].
Alibolandi, Mona ;
Ramezani, Mohammad ;
Abnous, Khalil ;
Sadeghi, Fatemeh ;
Hadizadeh, Farzin .
JOURNAL OF NANOPARTICLE RESEARCH, 2015, 17 (02)
[6]   Synthesis of AS1411-Aptamer-Conjugated CdTe Quantum Dots with High Fluorescence Strength for Probe Labeling Tumor Cells [J].
Alibolandi, Mona ;
Abnous, Khalil ;
Ramezani, Mohammad ;
Hosseinkhani, Hossein ;
Hadizadeh, Farzin .
JOURNAL OF FLUORESCENCE, 2014, 24 (05) :1519-1529
[7]  
Anajafi T, 2015, THER DELIV, V6, P521, DOI [10.4155/TDE.14.125, 10.4155/tde.14.125]
[8]   Biodegradable thermoresponsive polymeric magnetic nanoparticles: a new drug delivery platform for doxorubicin [J].
Andhariya, Nidhi ;
Chudasama, Bhupendra ;
Mehta, R. V. ;
Upadhyay, R. V. .
JOURNAL OF NANOPARTICLE RESEARCH, 2011, 13 (04) :1677-1688
[9]  
[Anonymous], UNE
[10]   Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin [J].
Arabi, Leila ;
Badiee, Ali ;
Mosaffa, Fatemeh ;
Jaafari, Mahmoud Reza .
JOURNAL OF CONTROLLED RELEASE, 2015, 220 :275-286